Metro Healthcare Berhad (KLSE:METRO)

Metro Healthcare Berhad Income Statement

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	47.92	48.65	44.69	40.27	42.26	28.33
Revenue Growth (YoY)	0.95%	8.87%	10.96%	-4.70%	49.14%	24.77%
Cost of Revenue	30.81	28.92	26.61	24.27	22.16	15.15
Gross Profit	17.11	19.73	18.08	16.01	20.09	13.18
Other Operating Expenses	12.53	12.32	9.21	8.71	8.11	7.46
Operating Expenses	12.53	12.32	9.21	8.71	8.11	7.46
Operating Income	4.58	7.4	8.87	7.3	11.98	5.72
Interest Expense	-0.66	-0.69	-0.73	-0.4	-0.37	-0.39
Interest & Investment Income	0.46	0.46	0.21	0.17	0.11	0.07
EBT Excluding Unusual Items	4.38	7.17	8.35	7.07	11.72	5.41
Gain (Loss) on Sale of Investments	-	-	-	0.08	0.79	1.82
Gain (Loss) on Sale of Assets	-	-	0.03	0.22	0.02	-
Other Unusual Items	-	-	0.16	0	0.07	0.05
Pretax Income	4.38	7.17	8.54	7.38	12.6	7.27
Income Tax Expense	1.85	2.61	2.29	2.36	3.17	1.79
Net Income	2.53	4.56	6.25	5.02	9.44	5.48
Net Income to Common	2.53	4.56	6.25	5.02	9.44	5.48
Net Income Growth	-61.17%	-27.02%	24.56%	-46.85%	72.32%	142.76%
Shares Outstanding (Basic)	1,057	979	822	822	822	808
Shares Outstanding (Diluted)	1,057	979	822	827	822	808
Shares Change (YoY)	28.57%	19.05%	-0.55%	0.55%	1.82%	0.62%
EPS (Basic)	0.00	0.00	0.01	0.01	0.01	0.01
EPS (Diluted)	0.00	0.00	0.01	0.01	0.01	0.01
EPS Growth	-69.67%	-38.70%	24.56%	-46.86%	69.25%	141.32%
Free Cash Flow	5.14	5.58	7.38	4.67	7.21	2.73
Free Cash Flow Per Share	0.01	0.01	0.01	0.01	0.01	0.00
Dividend Per Share	0.004	0.005	0.005	0.005	0.002	0.002
Dividend Growth	-25.93%	1.89%	6.00%	212.50%	6.67%	7.14%
Gross Margin	35.71%	40.55%	40.46%	39.74%	47.55%	46.53%
Operating Margin	9.55%	15.22%	19.85%	18.12%	28.36%	20.18%
Profit Margin	5.29%	9.37%	13.98%	12.46%	22.33%	19.33%
Free Cash Flow Margin	10.72%	11.46%	16.52%	11.60%	17.05%	9.62%
EBITDA	7.99	10.62	11.66	9.97	13.99	7.22
EBITDA Margin	16.68%	21.84%	26.10%	24.76%	33.10%	25.47%
D&A For EBITDA	3.42	3.22	2.79	2.68	2.01	1.5
EBIT	4.58	7.4	8.87	7.3	11.98	5.72
EBIT Margin	9.55%	15.22%	19.85%	18.12%	28.36%	20.18%
Effective Tax Rate	42.19%	36.43%	26.86%	32.01%	25.12%	24.68%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.